ASDactive: An Integrated Theory-based Intervention to Promote Habitual Physical Activity
Launched by ABERYSTWYTH UNIVERSITY · Jul 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ASDactive clinical trial is studying a new program designed to help young people with autism or Asperger's syndrome become more physically active. The goal is to find out if this program can change their habits and encourage them to engage in regular exercise. Researchers will gather information through interviews with participants and their families to see how well the program works, measuring physical activity levels before and after the intervention.
To participate, young people aged 10 to 24 who have been diagnosed with Level 1 autism or Asperger's syndrome may be eligible, as long as they do not have any physical conditions or injuries that would prevent them from being active. If selected, participants can expect to take part in activities aimed at increasing their physical activity in a supportive environment. This trial is currently recruiting participants, and it offers a chance to contribute to research that could benefit many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Young people aged 10-24-years diagnosed with Level 1 autism or Asperger's syndrome
- Exclusion Criteria:
- • Physical conditions or injuries that might hinder physical activity participation
About Aberystwyth University
Aberystwyth University is a distinguished institution dedicated to advancing research and education in the fields of science, health, and social sciences. Renowned for its commitment to innovation and excellence, the university actively engages in clinical trials that aim to enhance patient care and improve health outcomes. With a strong focus on collaboration and interdisciplinary approaches, Aberystwyth University leverages its academic expertise and state-of-the-art facilities to contribute valuable insights to the medical community, ensuring that its research has a meaningful impact on public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberystwyth, Ceredigion, United Kingdom
Patients applied
Trial Officials
Katherine Parsons
Principal Investigator
Aberystwyth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported